BMY

#128
Bristol-Myers Squibb Company Common Stock
57.1 8 USD
+0.62%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
56.82
57.26
年范围
42.52
62.89
日变化
+0.62%
每月变动
-0.92%
6个月变化
+15.94%
年变化
+19.50%
前一天收盘价
56.8 3
Open
56.9 0
最低价
56.8 2
High
57.2 6
交易量
7 641
展开完整图表 完整图表

Financials

概览 声明 统计 股息
每季度 年度
  • Market Capitalization 116.77 B
  • Employee 33 K
  • Founded N/A
  • CEO Chris Boerner
  • Website www.bms.com
  • Headquarter Delaware, United States
  • FIGI BBG000DQLV23
  • Industry 药品制造—常规
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
16.99
市销率
2.55
每股股息
0.63
股息收益率 %
7.19

Bristol-Myers Squibb Company Common Stock

Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2024, 71% of the company's revenues came from the United States. The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000.

新闻